Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women
ANNALS OF THE RHEUMATIC DISEASES
Authors: Lee, Hye-Soon; Kim, Taehyeung; Bang, So Young; Na, Young Ji; Kim, Il; Kim, Kwangwoo; Kim, Jae-Hoon; Chung, Yeun-Jun; Shin, Hyoung Doo; Kang, Young Mo; Shim, Seung-Cheol; Suh, Chang-Hee; Park, Yong-Beom; Kim, Jong-Sung; Kang, Changwon; Bae, Sang-Cheol
Abstract
Objectives To identify novel genetic candidates for systemic lupus erythematosus (SLE) in the Korean population, and to validate the risk loci for SLE identified in previous genome-wide association studies (GWAS). Methods We performed a GWAS in 400 Korean female SLE patients and 445 controls. Selected single-nucleotide polymorphisms (SNP) were then replicated in an independent cohort of 385 SLE patients and 583 controls (replication cohort 1), and in a further 811 SLE patients and 1502 controls (replication cohort 2). Results In the GWAS phase, rs9275428 located near HLA-DQB1 showed the strongest association with SLE (OR 0.50, false discovery rate (FDR) p=3.07x10(-6)). Although no loci reached genome-wide significance outside major histocompatibility complex (MHC), C8orf13-BLK, STAT4, CSMD1, DIAPH3, GLDC and TNFSF4 showed FDR p < 0.05. Our results suggest that STAT4, BLK, IRF5, PTTG1-miR-146a, UBE2L3 and TNFAIP3 are shared susceptibility loci among Caucasians and Asians, while ETS1, IKZF1, SLC15A4 are likely to be Asian-specific loci. In a combined analysis of 1596 SLE patients and 2540 controls for selected 22 candidate SNP, STAT4 and BLK as positive controls showed a strong association with SLE (FDR p=9.85x10(-13) and 2.28x10(-8), respectively). Of these, 16 candidates (PEX5L, TRAJ50, MYO18B, SOS1, ARHGAP26, SMURF1, CADPS, HAND1, FAM78B, DIAPH3, TBL1XR1, CSMD1, ZBTB20, C3orf21, HIPK1 and AP001042.1) showed only nominal significance (7.05x10(-4)<= FDR p <= 4.38x10(-2)). Conclusions There are similarities and differences in genetic susceptibility for SLE between Caucasian and Asian ethnic groups. Although 16 putative novel loci for SLE have been suggested in the Korean population, further research on a larger sample is required to discriminate truth from error.
Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans
ARTHRITIS & RHEUMATOLOGY
Authors: Lessard, Christopher J.; Sajuthi, Satria; Zhao, Jian; Kim, Kwangwoo; Ice, John A.; Li, He; Ainsworth, Hannah; Rasmussen, Astrid; Kelly, Jennifer A.; Marion, Miranda; Bang, So -Young; Bin Joo, Young; Choi, Jeongim; Lee, Hye-Soon; Kang, Young Mo; Suh, Chang-Hee; Chung, Won Tae; Lcc, Soo-Kon; Choc, Jung-Yoon; Shim, Scung Chcol; Oh, Ji Hcc; Kim, Young Jin; Han, Bok-Ghee; Shen, Nan; Howe, Hwee Siew; Wakeland, Edward K.; Li, Quan-Zhen; Song, Yeong Wook; Gaffney, Patrick M.; Alarcon-Riquelme, Marta E.; Criswel, Lindsey A.; Jacob, Chaim; Kimberly, Robert P.; Vyse, Timothy J.; Harley, John B.; Sivils, Kathy L.; Bae, Sang-Cheol; Langefeld, Carl D.; Tsao, Betty P.
Abstract
Objective. Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder whose etiology is incompletely understood, but likely involves environmental triggers in genetically susceptible individuals. Using an unbiased genome-wide association (GWA) scan and replication analysis, we sought to identify the genetic loci associated with SLE in a Korean population. Methods. A total of 1,174 SLE cases and 4,246 population controls from Korea were genotyped and analyzed with a GWA scan to identify single-nucleotide polymorphisms (SNPs) significantly associated with SLE, after strict quality control measures were applied. For select variants, replication of SLE risk loci was tested in an independent data set of 1,416 SLE cases and 1,145 population controls from Korea and China. Results. Eleven regions outside the HLA exceeded the genome-wide significance level (P = 5 x 10(-8)). A novel SNP-SLE association was identified between FCHSD2 and P2RY2, peaking at rs11235667 (P = 1.03 x 10(-8), odds ratio [OR] 0.59) on a 33-kb haplotype upstream of ATG16L2. In the independent replication data set, the SNP rs11235667 continued to show a significant association with SLE (replication meta-analysis P = 0.001, overall meta-analysis P = 6.67 3 10(-11); OR 0.63). Within the HLA region, the SNP-SLE association peaked in the class II region at rs116727542, with multiple independent effects observed in this region. Classic HLA allele imputation analysis identified HLA-DRB1*1501 and HLA-DQB1*0602, each highly correlated with one another, as most strongly associated with SLE. Ten previously established SLE risk loci were replicated: STAT1-STAT4, TNFSF4, TNFAIP3, IKZF1, HIP1, IRF5, BLK, WDFY4, ETS1, and IRAK1-MECP2. Of these loci, previously unreported, independent second risk effects of SNPs in TNFAIP3 and TNFSF4, as well as differences in the association with a putative causal variant in the WDFY4 region, were identified. Conclusion. Further studies are needed to identify true SLE risk effects in other loci suggestive of a significant association, and to identify the causal variants in the regions of ATG16L2, FCHSD2, and P2RY2.